160
Views
3
CrossRef citations to date
0
Altmetric
Original Research

A Cross-Sectional Study on the Correlation Between Inflammatory Cytokines, Negative Emotions, and Onset of Peripheral Neuropathy in Type 2 Diabetes

, , , &
Pages 2881-2890 | Published online: 01 Dec 2020

References

  • Zhou J, Zhou S. Inflammation: therapeutic targets for diabetic neuropathy. Mol Neurobiol. 2014;49(1):536–546. doi:10.1007/s12035-013-8537-023990376
  • King GL. The role of inflammatory cytokines in diabetes and its complications. J Periodontol. 2008;79(8 Suppl):1527–1534. doi:10.1902/jop.2008.08024618673007
  • Tesfaye S, Boulton AJM, Dickenson AH. Mechanisms and management of diabetic painful distal symmetrical polyneuropathy. Diabetes Care. 2013;36(9):2456–2465. doi:10.2337/dc12-196423970715
  • Said G. Diabetic neuropathy–a review. Nat Clin Pract Neurol. 2007;3(6):331–340. doi:10.1038/ncpneuro050417549059
  • Gore M, Brandenburg NA, Dukes E, Hoffman DL, Tai KS, Stacey B. Pain severity in diabetic peripheral neuropathy is associated with patient functioning, symptom levels of anxiety and depression, and sleep. J Pain Symptom Manage. 2005;30(4):374–385. doi:10.1016/j.jpainsymman.2005.04.00916256902
  • Hussain G, Rizvi SA, Singhal S, Zubair M, Ahmad J. Cross sectional study to evaluate the effect of duration of type 2 diabetes mellitus on the nerve conduction velocity in diabetic peripheral neuropathy. Diabetes Metab Syndr. 2014;8(1):48–52. doi:10.1016/j.dsx.2013.02.00324661759
  • Gok Metin Z, Arslan IE. Diabetic Peripheral Neuropathic Pain From the Perspective of Turkish Patients: A Qualitative Study. J Transcult Nurs. 2018;29(6):514–522. doi:10.1177/104365961775304429338623
  • Adamis AP. Is diabetic retinopathy an inflammatory disease? Br J Ophthalmol. 2002;86(4):363–365. doi:10.1136/bjo.86.4.36311914197
  • Dalla Vestra M, Mussap M, Gallina P, et al. Acute-phase markers of inflammation and glomerular structure in patients with type 2 diabetes. J Am Soc Nephrol. 2005;16(Suppl 1):S78–S82. doi:10.1681/asn.200411096115938041
  • Chow FY, Nikolic-Paterson DJ, Ozols E, Atkins RC, Tesch GH. Intercellular adhesion molecule-1 deficiency is protective against nephropathy in type 2 diabetic db/db mice. J Am Soc Nephrol. 2005;16(6):1711–1722. doi:10.1681/asn.200407061215857924
  • Hasegawa G, Nakano K, Sawada M, et al. Possible role of tumor necrosis factor and interleukin-1 in the development of diabetic nephropathy. Kidney Int. 1991;40(6):1007–1012. doi:10.1038/ki.1991.3081762301
  • Jin HY, Park TS. Role of inflammatory biomarkers in diabetic peripheral neuropathy. J Diabetes Investig. 2018;9(5):1016–1018. doi:10.1111/jdi.12794
  • Bilir B, Tulubas F, Bilir BE, et al. The association of vitamin D with inflammatory cytokines in diabetic peripheral neuropathy. J Phys Ther Sci. 2016;28(7):2159–2163. doi:10.1589/jpts.28.215927512288
  • Boulanger L, Zhao Y, Bao Y, Russell MW. A retrospective study on the impact of comorbid depression or anxiety on healthcare resource use and costs among diabetic neuropathy patients. BMC Health Serv Res. 2009;9(1):111. doi:10.1186/1472-6963-9-11119566952
  • Ur E, White PD, Grossman A. Hypothesis: cytokines may be activated to cause depressive illness and chronic fatigue syndrome. Eur Arch Psychiatry Clin Neurosci. 1992;241(5):317–322. doi:10.1007/bf021959831606197
  • Maes M. Evidence for an immune response in major depression: a review and hypothesis. Prog Neuropsychopharmacol Biol Psychiatry. 1995;19(1):11–38. doi:10.1016/0278-5846(94)00101-m7708925
  • Zung WW. A SELF-RATING DEPRESSION SCALE. Arch Gen Psychiatry. 1965;12:63–70. doi:10.1001/archpsyc.1965.0172031006500814221692
  • Jegede RO. Psychometric characteristics of Yoruba versions of Zung’s self-rating depression scale and self-rating anxiety scale. Afr J Med Med Sci. 1979;8(3–4):133–137.122316
  • Ge S, Xie J, Zheng L, et al. Associations of serum anti-ganglioside antibodies and inflammatory markers in diabetic peripheral neuropathy. Diabetes Res Clin Pract. 2016;115:68–75. doi:10.1016/j.diabres.2016.02.00527242125
  • Perkins BA, Olaleye D, Zinman B, Bril V. Simple screening tests for peripheral neuropathy in the diabetes clinic. Diabetes Care. 2001;24(2):250–256. doi:10.2337/diacare.24.2.25011213874
  • Herder C, Lankisch M, Ziegler D, et al. Subclinical inflammation and diabetic polyneuropathy: MONICA/KORA Survey F3 (Augsburg, Germany). Diabetes Care. 2009;32(4):680–682. doi:10.2337/dc08-201119131463
  • Herder C, Bongaerts BW, Rathmann W, et al. Association of subclinical inflammation with polyneuropathy in the older population: KORA F4 study. Diabetes Care. 2013;36(11):3663–3670. doi:10.2337/dc13-038224009302
  • Magrinelli F, Briani C, Romano M, et al. The Association between Serum Cytokines and Damage to Large and Small Nerve Fibers in Diabetic Peripheral Neuropathy. J Diabetes Res. 2015;2015:547834. doi:10.1155/2015/54783425961054
  • Littman DR, Rudensky AY. Th17 and regulatory T cells in mediating and restraining inflammation. Cell. 2010;140(6):845–858. doi:10.1016/j.cell.2010.02.02120303875
  • Habash T, Saleh A, Roy Chowdhury SK, Smith DR, Fernyhough P. The proinflammatory cytokine, interleukin-17A, augments mitochondrial function and neurite outgrowth of cultured adult sensory neurons derived from normal and diabetic rats. Exp Neurol. 2015;273:177–189. doi:10.1016/j.expneurol.2015.08.01626321687
  • Vas PRJ, Papanas N. Depression and Diabetic Peripheral Neuropathy: birds of a Feather, But When do They Flock Together? Exp Clin Endocrinol Diabetes. 2020;128(5):347–349. doi:10.1055/a-0808-426930562826
  • Yoo M, Sharma N, Pasnoor M, Kluding PM. Painful Diabetic Peripheral Neuropathy: presentations, Mechanisms, and Exercise Therapy. J Diabetes Metab. 2013;Suppl 10. doi:10.4172/2155-6156.S10-005
  • Smith KJ, Béland M, Clyde M, et al. Association of diabetes with anxiety: a systematic review and meta-analysis. J Psychosom Res. 2013;74(2):89–99. doi:10.1016/j.jpsychores.2012.11.01323332522
  • Liu Y, Ho RC-M, Mak A. The role of interleukin (IL)-17 in anxiety and depression of patients with rheumatoid arthritis. Int J Rheum Dis. 2012;15(2):183–187. doi:10.1111/j.1756-185X.2011.01673.x22462422
  • Henje Blom E, Lekander M, Ingvar M, Åsberg M, Mobarrez F, Serlachius E. Pro-inflammatory cytokines are elevated in adolescent females with emotional disorders not treated with SSRIs. J Affect Disord. 2012;136(3):716–723. doi:10.1016/j.jad.2011.10.00222056230
  • Yaghmaie P, Koudelka CW, Simpson EL. Mental health comorbidity in patients with atopic dermatitis. J Allergy Clin Immunol. 2013;131(2):428–433. doi:10.1016/j.jaci.2012.10.04123245818
  • Nanda MK, LeMasters GK, Levin L, et al. Allergic Diseases and Internalizing Behaviors in Early Childhood. Pediatrics. 2016;137:1. doi:10.1542/peds.2015-1922
  • Toth C, Au S. A prospective identification of neuropathic pain in specific chronic polyneuropathy syndromes and response to pharmacological therapy. Pain. 2008;138(3):657–666. doi:10.1016/j.pain.2008.04.02318691815
  • Li L, Chen J, Wang J, Cai D. Prevalence and risk factors of diabetic peripheral neuropathy in Type 2 diabetes mellitus patients with overweight/obese in Guangdong province, China. Prim Care Diabetes. 2015;9(3):191–195. doi:10.1016/j.pcd.2014.07.00625163987
  • De Vito P, Incerpi S, Pedersen JZ, Luly P, Davis FB, Davis PJ. Thyroid hormones as modulators of immune activities at the cellular level. Thyroid. 2011;21(8):879–890. doi:10.1089/thy.2010.042921745103
  • De Leo S, Lee SY, Braverman LE. Hyperthyroidism. Lancet. 2016;388(10047):906–918. doi:10.1016/s0140-6736(16)00278-627038492